Table 3.

Incidence of infection and GVHD in each group after HSCT.

	Normal	Mmild	Moderate	Severe	P
EBV n, (%)	0	1 (5.9)	2 (11.8)	13 (33.3)	0.020
CMV n, (%)	4 (26.7)	4 (23.5)	9 (52.9)	25 (64.1)	0.002
aGVHD n, (%)	3 (27.3)	2 (11.8)	1 (5.9)	6 (15.4)	0.570
Grade I n, (%)	2 (18.2)	2 (11.8)	0	4 (10.3)
Grade II n, (%)	1 (9.1)	0	1 (5.9)	2 (5.1)
cGVHD n, (%)
Moderate	0	0	0	1 (2.6)

EBV, epstein–barr virus, CMV, cytomegalovirus, GVHD, graft-versus-host disease. HSCT, haematopoietic stem cell transplantation.